NCT07262073

Brief Summary

This prospective, randomized controlled trial aims to compare perioperative respiratory changes in patients undergoing robot-assisted laparoscopic radical prostatectomy (RALRP) and open radical prostatectomy (ORP). The primary outcome is the change in peak expiratory flow (PEF) from the preoperative period to the early postoperative (2nd hour) period. Secondary outcomes include PEF recovery at 24 hours, and correlations between PEF change and intraoperative factors such as Trendelenburg angle, pneumoperitoneum duration, and ventilatory parameters.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
2mo left

Started Nov 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress78%
Nov 2025Jun 2026

Study Start

First participant enrolled

November 1, 2025

Completed
22 days until next milestone

First Submitted

Initial submission to the registry

November 23, 2025

Completed
10 days until next milestone

First Posted

Study publicly available on registry

December 3, 2025

Completed
27 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2026

Expected
Last Updated

December 3, 2025

Status Verified

October 1, 2025

Enrollment Period

2 months

First QC Date

November 23, 2025

Last Update Submit

November 23, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in PEF (L/min)

    Difference between preoperative and early postoperative PEF values.

    From preoperative baseline to postoperative 2nd hour

Secondary Outcomes (3)

  • Change in PEF from preoperative to postoperative 24th hour

    From preoperative measurement (baseline) to postoperative 24th hour

  • Intraoperative parameters correlated with PEF reduction

    From induction of anesthesia to end of surgery

  • Incidence of respiratory complications

    Within the first 24 hours after surgery

Study Arms (2)

Open Radical Prostatectomy (Control Group)

ACTIVE COMPARATOR

Patients undergoing open radical prostatectomy under standardized general anesthesia. No pneumoperitoneum or steep Trendelenburg position is applied.

Diagnostic Test: Surgical procedure: Robot-assisted laparoscopic radical prostatectomy

Robot-Assisted Laparoscopic Radical Prostatectomy (Study Group)

EXPERIMENTAL

Patients undergoing robot-assisted laparoscopic radical prostatectomy (RALRP) under standardized general anesthesia, with carbon dioxide pneumoperitoneum and Trendelenburg positioning.

Diagnostic Test: Surgical procedure: Robot-assisted laparoscopic radical prostatectomy

Interventions

RALRP will be performed with pneumoperitoneum (12-15 mmHg CO₂ insufflation) and 25-30° Trendelenburg position. Peak Expiratory Flow (PEF) will be measured preoperatively, 2 hours postoperatively, and 24 hours postoperatively using the same handheld peak flow meter.

Open Radical Prostatectomy (Control Group)Robot-Assisted Laparoscopic Radical Prostatectomy (Study Group)

Eligibility Criteria

Age18 Years - 80 Years
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male, 18-80 years old
  • ASA physical status I-III
  • Scheduled for open or robot-assisted radical prostatectomy
  • Able to provide informed consent and follow Turkish instructions

You may not qualify if:

  • Moderate/severe COPD (GOLD II-IV)
  • Active upper respiratory tract infection
  • Severe OSA requiring CPAP
  • Inability to perform standardized PEF maneuver
  • Emergency surgery
  • Cognitive impairment preventing participation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ankara Bilkent City Hospital, Department of Anesthesiology

Ankara, Çankaya, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Prostatic Neoplasms

Condition Hierarchy (Ancestors)

Genital Neoplasms, MaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsGenital Diseases, MaleGenital DiseasesUrogenital DiseasesProstatic DiseasesMale Urogenital Diseases

Study Officials

  • betül aytaç

    Ankara Bilkent City Hospital, Department of Anesthesiology

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 23, 2025

First Posted

December 3, 2025

Study Start

November 1, 2025

Primary Completion

December 30, 2025

Study Completion (Estimated)

June 30, 2026

Last Updated

December 3, 2025

Record last verified: 2025-10

Locations